Evidence map›Paper›PMID 27034804›Full record

ArticleJournal of gastrointestinal oncology2016

Metastatic colon cancer from extrahepatic cholangiocarcinoma presenting as painless jaundice: case report and literature review.

Benjamin W Vabi, Jeffrey Carter, Rong Rong, Minhua Wang, James G Corasanti, John F Gibbs

Abstract readCase Reports
In one paragraph

Article in Journal of gastrointestinal oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Benjamin W Vabi1 Department of Surgery, 2 Department of Pathology, University at Buffalo School of Medicine, 3 Department of Gastroenterology, Buffalo General Medical Center, Buffalo, NY, USA ; 4 Department of Surgery, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.
Jeffrey Carter1 Department of Surgery, 2 Department of Pathology, University at Buffalo School of Medicine, 3 Department of Gastroenterology, Buffalo General Medical Center, Buffalo, NY, USA ; 4 Department of Surgery, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.
Rong Rong1 Department of Surgery, 2 Department of Pathology, University at Buffalo School of Medicine, 3 Department of Gastroenterology, Buffalo General Medical Center, Buffalo, NY, USA ; 4 Department of Surgery, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.
Minhua Wang1 Department of Surgery, 2 Department of Pathology, University at Buffalo School of Medicine, 3 Department of Gastroenterology, Buffalo General Medical Center, Buffalo, NY, USA ; 4 Department of Surgery, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.
James G Corasanti1 Department of Surgery, 2 Department of Pathology, University at Buffalo School of Medicine, 3 Department of Gastroenterology, Buffalo General Medical Center, Buffalo, NY, USA ; 4 Department of Surgery, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.
John F Gibbs1 Department of Surgery, 2 Department of Pathology, University at Buffalo School of Medicine, 3 Department of Gastroenterology, Buffalo General Medical Center, Buffalo, NY, USA ; 4 Department of Surgery, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.
Buffalo General Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cholangiocarcinoma (CCA) is a rare cancer of the biliary epithelium comprising only about 3% of all gastrointestinal malignancies. It is a highly aggressive malignancy and confers a dismal prognosis with majority of patients presenting with metastatic disease. Metastatic CCA to the colon is extremely rare with only few cases reported in the literature. We present a 61-year-old patient with incidental synchronous metastatic colonic adenocarcinoma from extra-hepatic CCA. Laboratory data revealed significant indirect hyperbilirubinemia and transaminitis. Imaging study showed intrahepatic bile ducts prominence without mass lesions. Incidentally, there was diffuse colonic thickening without mass lesions or obstruction. Endoscopic retrograde cholangiopancreatography (ERCP) showed a common bile duct stricture. Brushings were consistent with CCA. Screening colonoscopy identified nodularity and biopsy and immunostaining were consistent with CCA metastasis to colon. The patient elected for palliative and comfort care. Metastatic CCA to the colon is a rare pattern of distant spread that may pose a diagnostic challenge. Some salient characteristics may assist in the differentiation of primary colon cancer and metastatic colon cancer from CCA. Little remains known about the pathogenic behavior of metastatic secondary colorectal cancer. And more so, the management approach to such metastatic cancer still remains to be defined. Screening colonoscopy in patients presenting with resectable CCA may alter management. Furthermore, whether patients with history of resected CCA may benefit from a more frequent screening colonoscopy remains to be validated.

Indexed as

Cholangiocarcinoma (CCA)jaundicemetastatic (secondary) colon cancerscreening colonoscopy

Identifiers

PMID27034804
PMCPMC4783741
OpenAlexW2173855316

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.